Literature DB >> 3817868

Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines.

C Sweet, R A Bird, K Jakeman, D M Coates, H Smith.   

Abstract

Neonatal ferrets may be passively immunized following maternal vaccination with formalin-inactivated influenza A virus vaccine, but the level of protection from partial to complete depends upon the number of doses used to vaccinate the mother, the presence or absence of aluminum hydroxide adjuvant, whether or not the mothers were 'primed' by prior infection with a serologically heterologous type A virus, and the age of the neonate at challenge. Neonates were completely protected up to 2 weeks of age, but susceptibility returned to nasal epithelium at 5 weeks and to lung at 7 weeks. Mothers immunized up to 9 months previously also partially or completely protected their offspring, this correlating with the maternal serum haemagglutination-inhibition (HI) antibody titre at the time of neonatal challenge, not the duration of immunity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817868      PMCID: PMC1453355     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Air-borne influenza virus A infections in immunized animals.

Authors:  C G LOOSLI; D HAMRE; B S BERLIN
Journal:  Trans Assoc Am Physicians       Date:  1953

2.  A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.

Authors:  R Jennings; C W Potter; C McLaren; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

3.  Immunity to influenza in ferrets. II. Influence of adjuvants on immunization.

Authors:  C W Potter; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

4.  Purification of influenza viruses using disulphide-linked immunosorbents derived from rabbit antibody.

Authors:  C Sweet; J Stephen; H Smith
Journal:  Immunochemistry       Date:  1974-06

5.  Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection.

Authors:  C W Potter; R Jennings; R C Rees; C McLaren
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.

Authors:  C W Potter; R Jennings; W M Marine; C McLaren
Journal:  Microbios       Date:  1973 Sep-Oct

7.  Immunity to influenza in ferrets. I. Response to live and killed virus.

Authors:  C W Potter; J S Oxford; S L Shore; C McLaren; C Stuart-Harris
Journal:  Br J Exp Pathol       Date:  1972-04

8.  Quantitative studies on the tissue localization of influenza virus in ferrets after intranasal and intravenous or intracardial inoculation.

Authors:  O Basarab; H Smith
Journal:  Br J Exp Pathol       Date:  1969-12

9.  The behaviour of antigenically related influenza viruses of differing virulence on disulphide-linked immunosorbents.

Authors:  C Sweet; J Stephen; H Smith
Journal:  Immunochemistry       Date:  1974-12

10.  Immunization of ferrets against influenza: a comparison of killed ferret grown and egg grown virus.

Authors:  C Sweet; J Stephen; H Smith
Journal:  Br J Exp Pathol       Date:  1974-06
View more
  11 in total

1.  Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.

Authors:  Huanhuan Ren; Guiqin Wang; Shuangshuang Wang; Honglin Chen; Zhiwei Chen; Hongxing Hu; Genhong Cheng; Paul Zhou
Journal:  MAbs       Date:  2016-05-11       Impact factor: 5.857

2.  Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.

Authors:  Zhizhen Qi; Haihong Zhao; Qingwen Zhang; Yujing Bi; Lingling Ren; Xuecan Zhang; Hanqing Yang; Xiaoyan Yang; Qiong Wang; Cunxiang Li; Jiyuan Zhou; Youquan Xin; Yonghai Yang; Huiying Yang; Zongmin Du; Yafang Tan; Yanping Han; Yajun Song; Lei Zhou; Pingping Zhang; Yujun Cui; Yanfeng Yan; Dongsheng Zhou; Ruifu Yang; Xiaoyi Wang
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

3.  A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.

Authors:  Hongxing Hu; Jarrod Voss; Guoliang Zhang; Philippi Buchy; Teng Zuo; Lulan Wang; Feng Wang; Fan Zhou; Guiqing Wang; Cheguo Tsai; Lesley Calder; Steve J Gamblin; Linqi Zhang; Vincent Deubel; Boping Zhou; John J Skehel; Paul Zhou
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

4.  Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.

Authors:  Y Okuno; K Matsumoto; Y Isegawa; S Ueda
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Authors:  I N Mbawuike; H R Six; T R Cate; R B Couch
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Authors:  Jens Wrammert; Dimitrios Koutsonanos; Gui-Mei Li; Srilatha Edupuganti; Jianhua Sui; Michael Morrissey; Megan McCausland; Ioanna Skountzou; Mady Hornig; W Ian Lipkin; Aneesh Mehta; Behzad Razavi; Carlos Del Rio; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Zahida Ali; Kaval Kaur; Sarah Andrews; Rama Rao Amara; Youliang Wang; Suman Ranjan Das; Christopher David O'Donnell; Jon W Yewdell; Kanta Subbarao; Wayne A Marasco; Mark J Mulligan; Richard Compans; Rafi Ahmed; Patrick C Wilson
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

7.  Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization.

Authors:  Joan E M van der Lubbe; Jessica Vreugdenhil; Sarra Damman; Joost Vaneman; Jaco Klap; Jaap Goudsmit; Katarina Radošević; Ramon Roozendaal
Journal:  Virol J       Date:  2017-06-26       Impact factor: 4.099

Review 8.  Harnessing Cellular Immunity for Vaccination against Respiratory Viruses.

Authors:  Nicholas W Lukacs; Carrie-Anne Malinczak
Journal:  Vaccines (Basel)       Date:  2020-12-21

Review 9.  The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.

Authors:  Melissa Rioux; Magen E Francis; Cynthia L Swan; Anni Ge; Andrea Kroeker; Alyson A Kelvin
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

10.  Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

Authors:  Cameron P Simmons; Nadia L Bernasconi; Amorsolo L Suguitan; Kimberly Mills; Jerrold M Ward; Nguyen Van Vinh Chau; Tran Tinh Hien; Federica Sallusto; Do Quang Ha; Jeremy Farrar; Menno D de Jong; Antonio Lanzavecchia; Kanta Subbarao
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.